Mcf Advisors LLC Care Dx, Inc. Transaction History
Mcf Advisors LLC
- $1.44 Billion
- Q2 2025
A detailed history of Mcf Advisors LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Mcf Advisors LLC holds 1,336 shares of CDNA stock, worth $16,993. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,336
Previous 340
292.94%
Holding current value
$16,993
Previous $6,000
333.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CDNA
# of Institutions
232Shares Held
56.6MCall Options Held
51.2KPut Options Held
46K-
Black Rock Inc. New York, NY5.29MShares$67.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.83MShares$61.5 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.67MShares$33.9 Million0.01% of portfolio
-
State Street Corp Boston, MA2.48MShares$31.6 Million0.0% of portfolio
-
Bamco Inc New York, NY2.19MShares$27.9 Million0.12% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $680M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...